Select Publications
Journal articles
2019, 'Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage', Journal of Hypertension, 37, pp. 1463 - 1466, http://dx.doi.org/10.1097/HJH.0000000000002056
,2019, 'Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes', Clinical Journal of the American Society of Nephrology, 14, pp. 862 - 872, http://dx.doi.org/10.2215/CJN.13391118
,2019, '409-P: Cardiac Biomarkers and Incident Peripheral Arterial Disease (PAD) in Patients with Type 2 Diabetes in the ADVANCE Trial', Diabetes, 68, http://dx.doi.org/10.2337/db19-409-p
,2019, 'Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus', Hypertension (Dallas, Tex. : 1979), 73, pp. 1291 - 1299, http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12414
,2019, 'Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke: a post hoc analysis of the HeadPoST study', Journal of Human Hypertension, 33, pp. 411 - 418, http://dx.doi.org/10.1038/s41371-019-0193-z
,2019, 'Infratentorial Intracerebral Hemorrhage: Relation of Location to Outcome', Stroke, 50, pp. 1257 - 1259, http://dx.doi.org/10.1161/STROKEAHA.118.023766
,2019, 'Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)', BMJ Open, 9, pp. e028698, http://dx.doi.org/10.1136/bmjopen-2018-028698
,2019, 'C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register', Diabetes Research and Clinical Practice, 150, pp. 174 - 183, http://dx.doi.org/10.1016/j.diabres.2019.03.014
,2019, 'EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes', Journal of Hypertension, 37, pp. 775 - 789, http://dx.doi.org/10.1097/HJH.0000000000001948
,2019, 'New Blood Pressure Guidelines Pose Difficult Choices for Australian Physicians', Circulation Research, 124, pp. 975 - 977, http://dx.doi.org/10.1161/CIRCRESAHA.118.314637
,2019, 'Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial', The Lancet, 393, pp. 877 - 888, http://dx.doi.org/10.1016/S0140-6736(19)30038-8
,2019, 'The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: The impact of enhanced research infrastructure on trial metrics and patient outcomes', Health Research Policy and Systems, 17, pp. 19, http://dx.doi.org/10.1186/s12961-019-0417-2
,2019, 'Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies', The Lancet Diabetes and Endocrinology, 7, pp. 115 - 127, http://dx.doi.org/10.1016/S2213-8587(18)30313-9
,2019, 'Medication reminder applications to improve adherence in coronary heart disease: A randomised clinical trial', Heart, 105, pp. 323 - 329, http://dx.doi.org/10.1136/heartjnl-2018-313479
,2019, 'Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium', American Journal of Kidney Diseases, 73, pp. 206 - 217, http://dx.doi.org/10.1053/j.ajkd.2018.08.013
,2019, 'Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.', European Heart Journal, 40, pp. 2899 - 2906, http://dx.doi.org/10.1093/eurheartj/ehy839
,2019, 'Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial', Hypertension, 73, pp. 84 - 91, http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12060
,2019, 'Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium', BMJ (Online), 364, pp. k5301, http://dx.doi.org/10.1136/bmj.k5301
,2019, 'Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 Study', Cerebrovascular Diseases Extra, 9, pp. 148 - 154, http://dx.doi.org/10.1159/000504531
,2019, 'Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage: The INTERACT-2 Study', Stroke, 50, pp. 1409 - 1414, http://dx.doi.org/10.1161/STROKEAHA.118.024403
,2019, 'Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: A systematic review of randomized trials', Journal of Hypertension, 37, pp. 16 - 23, http://dx.doi.org/10.1097/HJH.0000000000001994
,2019, 'Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial', Diabetes, Obesity and Metabolism, 22, pp. 452 - 457, http://dx.doi.org/10.1111/dom.13878
,2019, 'Abstract TP362: Comparison of the Simplified Modified Rankin Scale Questionnaire With Conventional Neurological Scales in the Dose Arm of the Enchanted Study', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.tp362
,2019, 'Abstract TP371: Adopting a Patient-centered Approach in Acute Stroke Trials With Utility-weighted Modified Rankin Scale Scores', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.tp371
,2019, 'Abstract WP107: Early Recurrence of Ischemic Stroke in Alteplase-treated Patients: The ENCHANTED Study', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.wp107
,2019, 'Polygenic risk scores predict diabetic complications and their response to therapy', , http://dx.doi.org/10.1101/19010785
,2019, 'SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES', Kidney International Reports, 4, pp. S128 - S128, http://dx.doi.org/10.1016/j.ekir.2019.05.325
,2019, 'SAT-294 RANDOMISED EFFECTS OF INTENSIVE GLUCOSE-LOWERING THERAPY ON THE RISK OF MAJOR CLINICAL OUTCOMES IN TYPE 2 DIABETES ACCORDING TO eGFR AND UACR LEVELS', Kidney International Reports, 4, pp. S131 - S131, http://dx.doi.org/10.1016/j.ekir.2019.05.334
,2018, 'Associations between body mass index and the risk of renal events in patients with type 2 diabetes', Nutrition and Diabetes, 8, pp. 7, http://dx.doi.org/10.1038/s41387-017-0012-y
,2018, 'NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke', Neurology, 91, pp. E1695 - E1701, http://dx.doi.org/10.1212/WNL.0000000000006437
,2018, 'Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy.', International Journal of Stroke, pp. 1 - 4, http://dx.doi.org/10.1177/1747493018806170
,2018, 'A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region', Journal of Hypertension, 36, pp. e306, http://dx.doi.org/10.1097/01.hjh.0000549252.23988.4b
,2018, 'PREDICTORS OF SEVERITY OF HYPERTENSIVE RESPONSE IN ACUTE INTRACEREBRAL HAEMORRHAGE', JOURNAL OF HYPERTENSION, 36, pp. E323 - E323, http://dx.doi.org/10.1097/01.hjh.0000549321.17364.3c
,2018, 'Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention', JCI insight, 3, http://dx.doi.org/10.1172/jci.insight.121326
,2018, '1109Medication reminder apps to improve medication adherence in coronary heart disease patients (MedApp-CHD): a randomised clinical trial', European Heart Journal, 39, http://dx.doi.org/10.1093/eurheartj/ehy565.1109
,2018, 'Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial', Cerebrovascular Diseases, 45, pp. 213 - 220, http://dx.doi.org/10.1159/000488911
,2018, 'Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study', Diabetes, Obesity and Metabolism, 20, pp. 1903 - 1910, http://dx.doi.org/10.1111/dom.13311
,2018, 'Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial', Diabetologia, 61, pp. 1581 - 1591, http://dx.doi.org/10.1007/s00125-018-4619-x
,2018, 'Polygenic Risk Testing at the Time of Diagnosis of Diabetes Could Help Prevent Its Micro- and Macrovascular Complications', Diabetes, 67, http://dx.doi.org/10.2337/db18-210-lb
,2018, 'Relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes mellitus: Results from the ADVANCE trial', Journal of the American Heart Association, 7, pp. e008226, http://dx.doi.org/10.1161/JAHA.117.008226
,2018, 'The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: An analysis of the TEXT ME study', International Journal of Behavioral Nutrition and Physical Activity, 15, pp. 45, http://dx.doi.org/10.1186/s12966-018-0677-1
,2018, 'Serumpotassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortiummeta-analysis', EUROPEAN HEART JOURNAL, 39, pp. 1535 - +, http://dx.doi.org/10.1093/eurheartj/ehy100
,2018, 'Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial', Journal of the Neurological Sciences, 387, pp. 1 - 5, http://dx.doi.org/10.1016/j.jns.2018.01.014
,2018, 'More on low-dose versus standard-dose intravenous alteplase in acute ischemic stroke', New England Journal of Medicine, 378, pp. 1465 - 1466, http://dx.doi.org/10.1056/NEJMc1801548
,2018, 'Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial', Diabetologia, 61, pp. 780 - 789, http://dx.doi.org/10.1007/s00125-017-4539-1
,2018, 'Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data', PLoS Medicine, 15, pp. e1002538, http://dx.doi.org/10.1371/journal.pmed.1002538
,2018, 'Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: The ADVANCE trial. Diabetes care 2017;40:1203-1209', Diabetes Care, 41, pp. e39, http://dx.doi.org/10.2337/dci17-0060
,2018, 'Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: An updated systematic review', Stroke and Vascular Neurology, 3, pp. 28 - 33, http://dx.doi.org/10.1136/svn-2017-000112
,2018, 'Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results from ADVANCE-ON', Diabetes Care, 41, pp. 163 - 170, http://dx.doi.org/10.2337/dc17-1467
,2018, 'Clinical utility of electronic Alberta stroke program early computed tomography score software in the ENCHANTED trial database', Stroke, 49, pp. 1407 - 1411, http://dx.doi.org/10.1161/STROKEAHA.117.019863
,